Archive - January 2023
The Time Is Now to Curb Spring Allergies
EMA validates first regulatory submission for CRISPR-based medicine
Bristol Myers Squibb sues AstraZeneca over alleged patent infringement of cancer drug
Eli Lilly plans to invest $450m at production site in Research Triangle Park
Poxel given EC’s Orphan Drug Designation for rare metabolic disorders
Thermo Fisher Scientific announces launch of CE-IVD marked assay to detect treatment-resistant strains of HIV-1
Coordination of COVID-19 vaccine clinical trials produces a ‘treasure trove’ of data and a model for the future
Persons with Disabilities Call for Inclusion in Creative Industry